Strategies and Approaches for Discovery of Small Molecule Disruptors of Biofilm Physiology von Trebino, Michael A, Shingare, Rahul D, MacMillan, John B, Yildiz, Fitnat H

Volltext

The Rvv two-component regulatory system regulates biofilm formation and colonization in Vibrio cholerae von Kitts, Giordan, Rogers, Andrew, Teschler, Jennifer K, Park, Jin Hwan, Trebino, Michael A, Chaudry, Issac, Erill, Ivan, Yildiz, Fitnat H

Volltext

Outer membrane vesicles and the outer membrane protein OmpU govern Vibrio cholerae biofilm matrix assembly von Potapova, Anna, Garvey, William, Dahl, Peter, Guo, Shuaiqi, Chang, Yunjie, Schwechheimer, Carmen, Trebino, Michael A, Floyd, Kyle A, Phinney, Brett S, Liu, Jun, Malvankar, Nikhil S, Yildiz, Fitnat H

Volltext

Utilizing imaging mass spectrometry to analyze microbial biofilm chemical responses to exogenous compounds von McCaughey, Catherine S, Trebino, Michael A, Yildiz, Fitnat H, Sanchez, Laura M

Volltext

A Label-Free Approach for Relative Spatial Quantitation of c‑di-GMP in Microbial Biofilms von McCaughey, Catherine S., Trebino, Michael A., McAtamney, Allyson, Isenberg, Ruth Y., Mandel, Mark J., Yildiz, Fitnat H., Sanchez, Laura M.

Volltext

Discovery of new piperidine amide triazolobenzodiazepinones as intestinal-selective CCK1 receptor agonists von Cameron, Kimberly O., Beretta, Elena E., Chen, Yue, Chu-Moyer, Margaret, Fernando, Dilinie, Gao, Hua, Kohrt, Jeffrey, Lavergne, Sophie, Jardine, Paul Da Silva, Guzman-Perez, Angel, Hoth, Christopher, Perry, David A., Hadcock, John R., Gautreau, Denise, Makowski, Michael, Perez, Sylvie, Polivkova, Jana, Rogers, Lucy, Scott, Dennis O., Swick, Andrew G., Thiede, Lucinda, Trebino, Catherine E., Trilles, Richard V., Wilmowski, Julie, Zhang, Yingxin

Volltext

Rapid Assessment of Cardiovascular Risk Among Users of Smoking Cessation Drugs Within the US Food and Drug Administration's Mini-Sentinel Program von Toh, Sengwee, Baker, Meghan A, Brown, Jeffrey S, Kornegay, Cynthia, Platt, Richard

Volltext

Structure–activity relationships of triazolopyridine oxazole p38 inhibitors: Identification of candidates for clinical development von McClure, Kim F., Letavic, Michael A., Kalgutkar, Amit S., Gabel, Christopher A., Audoly, Laurent, Barberia, John T., Braganza, John F., Carter, Demetrius, Carty, Thomas J., Cortina, Santo R., Dombroski, Mark A., Donahue, Kathleen M., Elliott, Nancy C., Gibbons, Colleen P., Jordan, Crystal K., Kuperman, Alexander V., Labasi, Jeff M., LaLiberte, Ronald E., McCoy, Jennifer M., Naiman, Brian M., Nelson, Kendra L., Nguyen, Hang T., Peese, Kevin M., Sweeney, Francis J., Taylor, Timothy J., Trebino, Catherine E., Abramov, Yuriy A., Laird, Ellen R., Volberg, Walter A., Zhou, Jun, Bach, Justin, Lombardo, Franco

Volltext